Landmark NIH Study Confirms MEF2 as a Master Regulator of Exercise Response
Melbourne, Australia — 1 May 2024
The NIH's Molecular Transducers of Physical Activity Consortium (MoTrPAC) today published a landmark study in Nature, providing the first comprehensive molecular map of the body's response to exercise training across 19 tissues.
The study independently confirmed MEF2 transcription factors as among the most critical mediators of exercise adaptation — a finding that directly validates Imitex's therapeutic approach. The research was conducted entirely independently of Imitex and represents large-scale, unbiased third-party confirmation of the target underpinning the company's entire drug discovery program.
"This is exactly the kind of independent validation that de-risks our approach for partners and investors," said Chief Scientific Officer Professor Sean McGee, whose own research on MEF2 spans more than two decades. "A study of this scale and rigour, published in Nature, confirming MEF2 as a master exercise regulator, is a watershed moment for the field — and for Imitex."